This inventor holds 1 USPTO granted patent. Top assignee: Emory University. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: David Chappell: Innovator in Pharmaceutical Chemistry
Introduction
David Chappell is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that interact with PK receptors. His research has the potential to impact various therapeutic areas.
Latest Patents
David Chappell holds a patent for a compound known as Haloisoquinoline carboxamide. This invention features a general structure where X, Y, or Z can be various elements or isotopes, and at least one of these components is not hydrogen. The compounds developed from this invention are designed to bind to PK receptors, showcasing their potential utility in medical applications. He has 1 patent to his name.
Career Highlights
Chappell is affiliated with Emory University, where he continues to engage in research and development in the field of chemistry. His work is characterized by a commitment to advancing scientific knowledge and creating innovative solutions in pharmaceuticals.
Collaborations
David has collaborated with esteemed colleagues such as Mark M. Goodman and Randolph E. Patterson. These partnerships have fostered a collaborative environment that enhances the research output and innovation potential.
Conclusion
David Chappell's contributions to pharmaceutical chemistry through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile